Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-09-028093
Filing Date
2009-05-21
Accepted
2009-05-21 16:02:08
Documents
1
Period of Report
2009-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 36668
  Complete submission text file 0001209191-09-028093.txt   38498
Mailing Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560
Business Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Issuer) CIK: 0001009356 (see all company filings)

EIN.: 943267443 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8540 COLONNADE CENTER DRIVE SUITE 501 RALEIGH NC 27615
Business Address
DERBYSHIRE ADAM C (Reporting) CIK: 0001212669 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23265 | Film No.: 09845503